0001562180-22-000353.txt : 20220107
0001562180-22-000353.hdr.sgml : 20220107
20220107211728
ACCESSION NUMBER: 0001562180-22-000353
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220106
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Engelhart James
CENTRAL INDEX KEY: 0001704255
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 22519448
MAIL ADDRESS:
STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP
STREET 2: 234 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-06
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001704255
Engelhart James
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
Strategic Advisor
Common Shares
2022-01-06
4
M
false
3750.00
0.00
A
15234.00
D
Common Shares
2022-01-06
4
F
false
1532.00
123.86
D
13702.00
D
Common Shares
2022-01-07
4
M
false
3250.00
0.00
A
16952.00
D
Common Shares
2022-01-07
4
F
false
1279.00
128.87
D
15673.00
D
Restricted Share Unit Award
2022-01-06
4
M
false
3750.00
0.00
D
Common Shares
3750.00
7500.00
D
Employee Stock Option (Right to Buy)
128.87
2022-01-07
4
A
false
26000.00
0.00
A
2032-01-07
Common Shares
26000.00
26000.00
D
Restricted Share Unit Award
2022-01-07
4
A
false
13000.00
0.00
A
Common Shares
13000.00
13000.00
D
Restricted Share Unit Award
2022-01-07
4
M
false
3250.00
0.00
D
Common Shares
3250.00
9750.00
D
This balance includes 288 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2021.
No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
Each restricted share unit represents the contingent right to receive one common share of the Issuer.
The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
Not applicable.
The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
The reporting person was granted 13,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date.
/s/ James Engelhart
2022-01-07